Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain
- PMID: 31132510
- DOI: 10.1016/j.jpain.2019.05.009
Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain
Abstract
Cannabis is commonly used to manage chronic pain, but cannabis use patterns among individuals with chronic pain, has not been well-characterized. We report cannabinoid, administration route, and product selection preferences among medical cannabis users with chronic pain from an ongoing, online survey. We also examined whether these preferences are affected by differences in sex, intentions behind use (medical only [MED] vs medical + recreational [MEDREC]), and experience with cannabis (novice: <1 year vs experienced: ≥1 year). The survey was completed by 1,321 participants (59% female) 76.5% of whom used cannabis every day. 93.4% used 2 or more administration routes and 72.5% used 3 or more. Female, MED, and novice users were less likely to smoke or vaporize (all P < .0001), but more likely to rank edibles, tinctures, and topicals as a first-choice administration route than their counterparts. Female and MED users also preferred low THC: high cannabidiol ratios significantly more than their counterparts. Overall, only 2.6% of participants selected cannabis products with input from a medical professional, although 54.9% relied on advice from dispensary employees. More male, MEDREC, and experienced users selected products based on factors that reflected greater comfort with cannabis (eg, smell, visual properties, cannabis variety). The wide variability in cannabis use among these different groups indicates the need for further research to investigate how specific use routines relate to clinical outcomes. PERSPECTIVE: Medical cannabis users with chronic pain show distinct differences in cannabinoid preferences and administration associated with user sex, intentions behind use, and experience with cannabis. This article highlights the wide variability in cannabis preferences among medical cannabis users with chronic pain, which may be relevant for clinical outcomes.
Keywords: CBD; Cannabis; THC; administration route; cannabis use routine.
Copyright © 2019 the American Pain Society. Published by Elsevier Inc. All rights reserved.
Similar articles
-
High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain.J Pain. 2020 May-Jun;21(5-6):570-581. doi: 10.1016/j.jpain.2019.09.006. Epub 2019 Sep 24. J Pain. 2020. PMID: 31560957 Free PMC article.
-
Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain.J Pain. 2019 Jul;20(7):830-841. doi: 10.1016/j.jpain.2019.01.010. Epub 2019 Jan 26. J Pain. 2019. PMID: 30690169
-
The impacts of potency, warning messages, and price on preferences for Cannabis flower products.Int J Drug Policy. 2019 Dec;74:1-10. doi: 10.1016/j.drugpo.2019.07.037. Epub 2019 Aug 2. Int J Drug Policy. 2019. PMID: 31382201 Free PMC article.
-
Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review.BMJ Open. 2021 Sep 7;11(9):e050831. doi: 10.1136/bmjopen-2021-050831. BMJ Open. 2021. PMID: 34493521 Free PMC article.
-
Medical Cannabis for Headache Pain: a Primer for Clinicians.Curr Pain Headache Rep. 2021 Oct 9;25(10):64. doi: 10.1007/s11916-021-00974-z. Curr Pain Headache Rep. 2021. PMID: 34628531 Review.
Cited by
-
Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany.Pharmacopsychiatry. 2024 May;57(3):133-140. doi: 10.1055/a-2261-2269. Epub 2024 Mar 12. Pharmacopsychiatry. 2024. PMID: 38471525 Free PMC article.
-
Predictors of Response to Medical Cannabis for Chronic Pain: A Retrospective Review of Real-Time Observational Data.Cannabis. 2024 Dec 12;7(3):167-176. doi: 10.26828/cannabis/2024/000259. eCollection 2024. Cannabis. 2024. PMID: 39781554 Free PMC article.
-
Human olfactory discrimination of genetic variation within Cannabis strains.Front Psychol. 2022 Oct 28;13:942694. doi: 10.3389/fpsyg.2022.942694. eCollection 2022. Front Psychol. 2022. PMID: 36389460 Free PMC article.
-
Cannabis consumers' preferences for legal and illegal cannabis: evidence from a discrete choice experiment.BMC Public Health. 2024 Sep 4;24(1):2397. doi: 10.1186/s12889-024-19640-1. BMC Public Health. 2024. PMID: 39227852 Free PMC article.
-
The Anticonvulsant Effects of Different Cannabis Extracts in a Zebrafish Model of Epilepsy.Biomolecules. 2025 May 1;15(5):654. doi: 10.3390/biom15050654. Biomolecules. 2025. PMID: 40427547 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical